Results 91 to 100 of about 278,985 (182)

Dopamine Agonists in the Management of Non-Functioning Pituitary Adenomas. [PDF]

Acta Endocrinol (Buchar), 2021
Capatina C, Poiana C.
europepmc   +1 more source

Othello Syndrome Induced by Dopamine Agonists in Parkinson's Disease: A Case Report. [PDF]

Case Rep Psychiatry
Ahmed GU, Ahmed HU, Raza AA, Samadi A.
europepmc   +1 more source

Quantitative Evaluation of Pupil Responses in Patients with Prolactinomas Being Treated with Dopamine Agonists. [PDF]

Neuroophthalmology, 2022
Ava S, Hazar L, Karahan M, Erdem S, Dursun ME, Pekkolay Z, Keklikçi U.   +6 more
europepmc   +1 more source

Dopamine Agonists Used as Monotherapy in De Novo PD Patients: Comparisons With Selegiline

, 1992
Studies indicate that selegiline, a monoamine oxidase type B inhibitor, slows progression of Parkinson\u27s disease (PD) and delays th need for levodopa.
Lieberman, Abraham N.
core  

Prolactin secreting pituitary neuroendocrine tumors treated by dopamine agonists: predictors of response. [PDF]

Front Endocrinol (Lausanne)
Mele C, Zavattaro M, Pitino R, Romanisio M, Ferrero A, Sturnia S, Catenazzi S, Rosmini F, Baldi S, Marzullo P, Aimaretti G, Prodam F, Caputo M.   +12 more
europepmc   +1 more source

Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis. [PDF]

Chin Neurosurg J, 2022
Cai X, Zhu J, Yang J, Tang C, Cong Z, Ma C.   +5 more
europepmc   +1 more source

Pulmonary Fibrosis in a Patient With a Prolactinoma on Dopamine Agonists: Coincidence or Consequence. [PDF]

JCEM Case Rep
Shah R, Bal A, Arjunan D, Ghosh J, Grossman AB, Dutta P.   +5 more
europepmc   +1 more source

Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein. [PDF]

Bioorg Med Chem, 2023
Dinda B, Das B, Biswas S, Sharma H, Armstrong C, Yedlapudi D, Antonio T, Reith M, Dutta AK.   +8 more
europepmc   +1 more source

A Comparison of Short and Long-Term Acting Dopamine Agonists in the Treatment of Parkinson's Disease with Respect to the Side Effects of Impulse Control Disorder. [PDF]

J Clin Pract Res
Oruc HG, Yildiz BT.
europepmc   +1 more source

Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists. [PDF]

Front Endocrinol (Lausanne), 2021
Tang H, Cheng Y, Huang J, Li J, Zhang B, Wu ZB.   +5 more
europepmc   +1 more source